1. Collins SM. A case for an immunological basis for irritable bowel syndrome. Gastroenterology 2002; 122: 2078–80.
2. Gwee KA, Collins SM, Read NW et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infection irritable bowel syndrome. Gut 2003; 52: 523–6.
3. Gwee KA, Leong YL, Graham C et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999; 44 (3): 400–6.
4. Spiller RC, Jenkins D, Thornley JP et al. Increased rectal mucosal enteroendocrine cells, t lymphocytes and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804–11.
5. Roberfroid MB. Global view on functional foods: European perspectives. British J Nutrition 2002; 88 (Suppl. 2): 133–8.
6. Шендеров Б.А., Манвелова М.А. Функциональное питание. Микроэкологические аспекты. М.: Изд-во МЗ РФ, 1994.
7. Woollen A. Functional foods – a new market? Food Rev 1990; 17 (4): 63–4.
8. Парфенов А.И., Ручкина И.Н. Профилактика и лечение запоров пробиотиками. Фарматека. 2006; 12 (127): 23–9.
9. Guyonnet D, Chassany O, Ducrott ОP et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on bloating and health-related quality of life in Irritable Bowel Syndrome (IBS) adult patients. A randomized, double-blind, controlled trial. Poster presentation at the Neurogastroenterology and Motility Joint international Meeting, September 14–17, 2006, Boston.
Авторы
И.В.Стасева
Консультативно-диагностический центр многопрофильной клиники "Центр эндохирургии и литотрипсии", Москва